PEGINTERFERON ALFA2b PLUS TDF TREATMENT OF HBEAG- NEGATIVE CHRONIC HEPATITIS B PATIENTS IN INDETERMINATE PHASE: A PILOT, OPEN- LABEL, PROSPECTIVE COHORT STUDY
第一作者机构:[1]First Peoples Hosp Yunnan Prov, Kunming, Yunnan, Peoples R China
推荐引用方式(GB/T 7714):
Liu Min,Zhang Yuting,Zuo Lili,et al.PEGINTERFERON ALFA2b PLUS TDF TREATMENT OF HBEAG- NEGATIVE CHRONIC HEPATITIS B PATIENTS IN INDETERMINATE PHASE: A PILOT, OPEN- LABEL, PROSPECTIVE COHORT STUDY[J].HEPATOLOGY.2023,78:S538-S539.
APA:
Liu, Min,Zhang, Yuting,Zuo, Lili,Xiao, An,Yue, Wei...&Xia, Xueshan.(2023).PEGINTERFERON ALFA2b PLUS TDF TREATMENT OF HBEAG- NEGATIVE CHRONIC HEPATITIS B PATIENTS IN INDETERMINATE PHASE: A PILOT, OPEN- LABEL, PROSPECTIVE COHORT STUDY.HEPATOLOGY,78,
MLA:
Liu, Min,et al."PEGINTERFERON ALFA2b PLUS TDF TREATMENT OF HBEAG- NEGATIVE CHRONIC HEPATITIS B PATIENTS IN INDETERMINATE PHASE: A PILOT, OPEN- LABEL, PROSPECTIVE COHORT STUDY".HEPATOLOGY 78.(2023):S538-S539